Argomento di ricerca

Longevity & Aging

Aging biology, lifespan extension, hallmarks of aging, and healthspan optimization

3829 articoli

Brain Metastases Strike 1 in 3 HER2-Positive Breast Cancer Patients Within 5 Years
Longevity & Aging

Brain Metastases Strike 1 in 3 HER2-Positive Breast Cancer Patients Within 5 Years

New real-world data reveal alarming brain metastasis rates in HER2-positive breast cancer, while experts debate when and whether to screen.

Comunicato stampa
23 giu 2026 0
Health System Cuts Unnecessary Blood Thinner Prescriptions by Targeting Overuse
Longevity & Aging

Health System Cuts Unnecessary Blood Thinner Prescriptions by Targeting Overuse

A VA health system reduced risky antiplatelet overprescribing in DOAC patients using clinician education and smart electronic alerts.

Comunicato stampa
23 giu 2026 0
Semaglutide Plus Lifestyle Counseling Tops All Treatments for Childhood Obesity
Longevity & Aging

Semaglutide Plus Lifestyle Counseling Tops All Treatments for Childhood Obesity

A major meta-analysis finds GLP-1 drugs combined with counseling cut BMI most in kids, but lifestyle treatment alone still delivers strong results.

Comunicato stampa
23 giu 2026 0
Off-the-Shelf Cancer Drug Teclistamab Shows Promise for Severe Autoimmune Disease
Longevity & Aging

Off-the-Shelf Cancer Drug Teclistamab Shows Promise for Severe Autoimmune Disease

A case series of 18 patients found teclistamab helped most with refractory autoimmune diseases, but serious risks remain.

Comunicato stampa
23 giu 2026 0
Doctors Prescribe Antibiotics for Diverticulitis 97% of the Time Despite Guidelines
Longevity & Aging

Doctors Prescribe Antibiotics for Diverticulitis 97% of the Time Despite Guidelines

A VA study finds antibiotics are vastly overprescribed for uncomplicated diverticulitis, raising gut microbiome and resistance concerns.

Comunicato stampa
23 giu 2026 0
New Blood Test Outperforms PSA at Catching Dangerous Prostate Cancers
Longevity & Aging

New Blood Test Outperforms PSA at Catching Dangerous Prostate Cancers

The Stockholm3 test detected 90% of clinically significant prostate cancers vs 74% for PSA, with nearly identical false-positive rates.

Comunicato stampa
23 giu 2026 0
Fast-Walking Octogenarians Have Half the Cognitive Decline Risk of Peers
Longevity & Aging

Fast-Walking Octogenarians Have Half the Cognitive Decline Risk of Peers

Adults 80+ who walk as fast as 50-year-olds show dramatically lower dementia risk and preserved brain volume, new multi-cohort data reveals.

Comunicato stampa
23 giu 2026 0
Delaying CIN2 Treatment Cuts Unnecessary Procedures Without Raising Cancer Risk
Longevity & Aging

Delaying CIN2 Treatment Cuts Unnecessary Procedures Without Raising Cancer Risk

New research shows waiting 6+ months before treating CIN2 cervical lesions doesn't increase cancer risk and reduces needless surgeries.

Comunicato stampa
23 giu 2026 0
LSD Therapy Shows Strong Phase 3 Results for Major Depression
Longevity & Aging

LSD Therapy Shows Strong Phase 3 Results for Major Depression

Definium's single-dose LSD pill cut depression scores by 13 points vs 5 for placebo, with effects holding at 12 weeks.

Comunicato stampa
23 giu 2026 0
Tropical Butterfly That Barely Ages May Reveal New Clues to Longevity
Longevity & Aging

Tropical Butterfly That Barely Ages May Reveal New Clues to Longevity

Heliconius butterflies live up to 25x longer than relatives and show no physical decline — scientists want to know why.

Comunicato stampa
23 giu 2026 0
Sticky RNA-DNA Loops in Senescent Cells Drive Chronic Inflammation
Longevity & Aging

Sticky RNA-DNA Loops in Senescent Cells Drive Chronic Inflammation

Scientists discover R-loops in senescent cells trigger inflammatory secretions, linking a transcription glitch to a key aging mechanism.

Comunicato stampa
23 giu 2026 0
CRISPR Startup Gets $25M to Target Lp(a) and Triglycerides With One-Time Gene Edits
Longevity & Aging

CRISPR Startup Gets $25M to Target Lp(a) and Triglycerides With One-Time Gene Edits

Scribe Therapeutics wins $25M in funding to advance two CRISPR programs targeting dangerous lipid drivers of heart disease toward clinical trials.

Comunicato stampa
23 giu 2026 0
Pagina 1 di 320Avanti